BioSig Technologies, Inc. (29)

Browse by Contract Category

Contracts

Form of Underwriter Warrant (Filed With SEC on July 6, 2021)
Availability Retainer Agreement, dated June 30, 2021, by and between BioSig Technologies, Inc. and Jeffrey ODonnell (Filed With SEC on July 1, 2021)
Ninth Amendment to the BioSig Technologies, Inc. 2012 Equity Incentive Plan (Filed With SEC on June 29, 2021)
Amendment No. 2 to Assignment and License Agreement, dated as of September 2, 2020, by and among ViralClear Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated (Filed With SEC on September 3, 2020)
Lease Agreement, dated October 1, 2019, by and between CMD Holdings LLC and BioSig Technologies, Inc (Filed With SEC on October 23, 2019)
Underwriting Agreement, dated July 2, 2021, by and between BioSig Technologies, Inc. and Laidlaw & Company (UK) Ltd (Filed With SEC on July 6, 2021)
Availability Retainer Agreement, dated June 24, 2021, by and between BioSig Technologies, Inc. and Jeffrey ODonnell (Filed With SEC on June 25, 2021)
Description of Securities (Filed With SEC on March 15, 2021)
Open Market Sale AgreementSM, dated August 28, 2020, by and between BioSig Technologies, Inc. and Jefferies LLC (Filed With SEC on August 28, 2020)
Rights Agreement dated as of July 14, 2020 between BioSig Technologies, Inc. and Action Stock Transfer Corporation, as Rights Agent (Filed With SEC on July 17, 2020)
Eighth Amendment to the BioSig Technologies, Inc. 2012 Equity Incentive Plan (Filed With SEC on June 30, 2020)
Form of Securities Purchase Agreement (Filed With SEC on June 26, 2020)
Asset Purchase Agreement, dated as of March 24, 2020, by and between Trek Therapeutics, PBC and NeuroClear Technologies, Inc (Filed With SEC on May 11, 2020)
Assignment and License Agreement, dated as of July 12, 2016, by and between Vertex Pharmaceuticals Incorporated and Trek Therapeutics, PBC (Filed With SEC on May 11, 2020)
Description of Securities (Filed With SEC on March 13, 2020)
Common Stock Purchase Warrant of BioSig Technologies, Inc., dated November 20, 2019, issued to Mayo Foundation for Medical Education and Research (EP Software Warrant) (Filed With SEC on March 13, 2020)
Common Stock Purchase Warrant of BioSig Technologies, Inc., dated November 20, 2019, issued to Mayo Foundation for Medical Education and Research (Tools Warrant) (Filed With SEC on March 13, 2020)
Common Stock Purchase Warrant of NeuroClear Technologies, Inc., dated November 20, 2019, issued to Mayo Clinic Ventures (Filed With SEC on March 13, 2020)
Underwriter Agreement, dated February 21, 2020, by and between BioSig Technologies, Inc. and Laidlaw & Company (UK) Ltd (Filed With SEC on February 24, 2020)
Form of Underwriter Warrant (Filed With SEC on February 24, 2020)
Form of Securities Purchase Agreement (Filed With SEC on December 31, 2019)
Seventh Amendment to the BioSig Technologies, Inc. 2012 Equity Incentive Plan (Filed With SEC on November 20, 2019)
Form of Securities Purchase Agreement (Filed With SEC on October 25, 2019)
Patent License Agreement, dated September 12, 2019, by and between Mayo Foundation for Medical Education and Research and BioSig Technologies, Inc (Filed With SEC on October 23, 2019)
Form of Securities Purchase Agreement (Filed With SEC on September 5, 2019)
Form of Securities Purchase Agreement (Filed With SEC on August 5, 2019)
First Amendment to Stock Option Agreement, dated May 17, 2019, between Roy T. Tanaka and BioSig Technologies, Inc (Filed With SEC on May 22, 2019)
First Amendment to Stock Option Agreement, dated May 17, 2019, between Seth H.Z. Fischer and BioSig Technologies, Inc (Filed With SEC on May 22, 2019)
Form of Securities Purchase Agreement (Filed With SEC on March 14, 2019)